Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 31

1.

Impaired Amino Acid and TCA Metabolism and Cardiovascular Autonomic Neuropathy Progression in Type 1 Diabetes.

Mathew AV, Jaiswal M, Ang L, Michailidis G, Pennathur S, Pop-Busui R.

Diabetes. 2019 Jul 23. pii: db190145. doi: 10.2337/db19-0145. [Epub ahead of print]

PMID:
31337616
2.

AMP-activated protein kinase activation ameliorates eicosanoid dysregulation in high-fat-induced kidney disease in mice.

Declèves AE, Mathew AV, Armando AM, Han X, Dennis EA, Quehenberger O, Sharma K.

J Lipid Res. 2019 May;60(5):937-952. doi: 10.1194/jlr.M088690. Epub 2019 Mar 12.

3.

Host NLRP6 exacerbates graft-versus-host disease independent of gut microbial composition.

Toubai T, Fujiwara H, Rossi C, Riwes M, Tamaki H, Zajac C, Liu C, Mathew AV, Byun J, Oravecz-Wilson K, Matsuda I, Sun Y, Peltier D, Wu J, Chen J, Seregin S, Henig I, Kim S, Brabbs S, Pennathur S, Chen G, Reddy P.

Nat Microbiol. 2019 May;4(5):800-812. doi: 10.1038/s41564-019-0373-1. Epub 2019 Mar 11.

PMID:
30858572
4.
5.

Salt-Responsive Metabolite, β-Hydroxybutyrate, Attenuates Hypertension.

Chakraborty S, Galla S, Cheng X, Yeo JY, Mell B, Singh V, Yeoh B, Saha P, Mathew AV, Vijay-Kumar M, Joe B.

Cell Rep. 2018 Oct 16;25(3):677-689.e4. doi: 10.1016/j.celrep.2018.09.058.

6.

Gut Microbial Product Predicts Cardiovascular Risk in Chronic Kidney Disease Patients.

Jadoon A, Mathew AV, Byun J, Gadegbeku CA, Gipson DS, Afshinnia F, Pennathur S; for the Michigan Kidney Translational Core CPROBE Investigator Group.

Am J Nephrol. 2018;48(4):269-277. doi: 10.1159/000493862. Epub 2018 Oct 16.

PMID:
30326477
7.

Therapeutic Lifestyle Changes Improve HDL Function by Inhibiting Myeloperoxidase-Mediated Oxidation in Patients With Metabolic Syndrome.

Mathew AV, Li L, Byun J, Guo Y, Michailidis G, Jaiswal M, Chen YE, Pop-Busui R, Pennathur S.

Diabetes Care. 2018 Nov;41(11):2431-2437. doi: 10.2337/dc18-0049. Epub 2018 Sep 10.

PMID:
30201848
8.

Disparate effects of antibiotics on hypertension.

Galla S, Chakraborty S, Cheng X, Yeo J, Mell B, Zhang H, Mathew AV, Vijay-Kumar M, Joe B.

Physiol Genomics. 2018 Oct 1;50(10):837-845. doi: 10.1152/physiolgenomics.00073.2018. Epub 2018 Aug 10.

PMID:
30095376
9.

Effect of Ambient Fine Particulate Matter Air Pollution and Colder Outdoor Temperatures on High-Density Lipoprotein Function.

Mathew AV, Yu J, Guo Y, Byun J, Chen YE, Wang L, Liu M, Bard RL, Morishita M, Huang W, Li J, Harkema JR, Rajagopalan S, Pennathur S, Brook RD.

Am J Cardiol. 2018 Aug 15;122(4):565-570. doi: 10.1016/j.amjcard.2018.04.061. Epub 2018 Jul 11.

10.

Myeloperoxidase-derived oxidants damage artery wall proteins in an animal model of chronic kidney disease-accelerated atherosclerosis.

Zeng L, Mathew AV, Byun J, Atkins KB, Brosius FC 3rd, Pennathur S.

J Biol Chem. 2018 May 11;293(19):7238-7249. doi: 10.1074/jbc.RA117.000559. Epub 2018 Mar 26.

11.

Myeloperoxidase mediated HDL oxidation and HDL proteome changes do not contribute to dysfunctional HDL in Chinese subjects with coronary artery disease.

Wang G, Mathew AV, Yu H, Li L, He L, Gao W, Liu X, Guo Y, Byun J, Zhang J, Chen YE, Pennathur S.

PLoS One. 2018 Mar 5;13(3):e0193782. doi: 10.1371/journal.pone.0193782. eCollection 2018.

12.

Apolipoprotein A-1 mimetic peptide 4F promotes endothelial repairing and compromises reendothelialization impaired by oxidized HDL through SR-B1.

He D, Zhao M, Wu C, Zhang W, Niu C, Yu B, Jin J, Ji L, Willard B, Mathew AV, Chen YE, Pennathur S, Yin H, He Y, Pan B, Zheng L.

Redox Biol. 2018 May;15:228-242. doi: 10.1016/j.redox.2017.11.027. Epub 2017 Dec 8.

13.

Deficiency of Cholesteryl Ester Transfer Protein Protects Against Atherosclerosis in Rabbits.

Zhang J, Niimi M, Yang D, Liang J, Xu J, Kimura T, Mathew AV, Guo Y, Fan Y, Zhu T, Song J, Ackermann R, Koike Y, Schwendeman A, Lai L, Pennathur S, Garcia-Barrio M, Fan J, Chen YE.

Arterioscler Thromb Vasc Biol. 2017 Jun;37(6):1068-1075. doi: 10.1161/ATVBAHA.117.309114. Epub 2017 Apr 20.

14.

Circulating Modified Metabolites and a Risk of ESRD in Patients With Type 1 Diabetes and Chronic Kidney Disease.

Niewczas MA, Mathew AV, Croall S, Byun J, Major M, Sabisetti VS, Smiles A, Bonventre JV, Pennathur S, Krolewski AS.

Diabetes Care. 2017 Mar;40(3):383-390. doi: 10.2337/dc16-0173. Epub 2017 Jan 13.

15.

Corrigendum: Gut microbiome-derived metabolites modulate intestinal epithelial cell damage and mitigate graft-versus-host disease.

Mathewson ND, Jenq R, Mathew AV, Koenigsknecht M, Hanash A, Toubai T, Oravecz-Wilson K, Wu SR, Sun Y, Rossi C, Fujiwara H, Byun J, Shono Y, Lindemans C, Calafiore M, Schmidt TM, Honda K, Young VB, Pennathur S, van den Brink M, Reddy P.

Nat Immunol. 2016 Sep 20;17(10):1235. doi: 10.1038/ni1016-1235b. No abstract available.

PMID:
27648549
16.

Gut microbiome-derived metabolites modulate intestinal epithelial cell damage and mitigate graft-versus-host disease.

Mathewson ND, Jenq R, Mathew AV, Koenigsknecht M, Hanash A, Toubai T, Oravecz-Wilson K, Wu SR, Sun Y, Rossi C, Fujiwara H, Byun J, Shono Y, Lindemans C, Calafiore M, Schmidt TM, Honda K, Young VB, Pennathur S, van den Brink M, Reddy P.

Nat Immunol. 2016 May;17(5):505-513. doi: 10.1038/ni.3400. Epub 2016 Mar 21. Erratum in: Nat Immunol. 2016 Sep 20;17 (10 ):1235.

17.

Metabolomic Profiling of Arginine Metabolome Links Altered Methylation to Chronic Kidney Disease Accelerated Atherosclerosis.

Mathew AV, Zeng L, Byun J, Pennathur S.

J Proteomics Bioinform. 2015 Oct;Suppl 14. pii: 001. Epub 2015 May 18.

18.

Altered Metabolic Profile With Sodium-Restricted Dietary Approaches to Stop Hypertension Diet in Hypertensive Heart Failure With Preserved Ejection Fraction.

Mathew AV, Seymour EM, Byun J, Pennathur S, Hummel SL.

J Card Fail. 2015 Dec;21(12):963-7. doi: 10.1016/j.cardfail.2015.10.003. Epub 2015 Oct 20.

19.

High density lipoprotein promotes proliferation of adipose-derived stem cells via S1P1 receptor and Akt, ERK1/2 signal pathways.

Shen H, Zhou E, Wei X, Fu Z, Niu C, Li Y, Pan B, Mathew AV, Wang X, Pennathur S, Zheng L, Wang Y.

Stem Cell Res Ther. 2015 May 15;6:95. doi: 10.1186/s13287-015-0090-5.

20.

Evidence for a link between gut microbiota and hypertension in the Dahl rat.

Mell B, Jala VR, Mathew AV, Byun J, Waghulde H, Zhang Y, Haribabu B, Vijay-Kumar M, Pennathur S, Joe B.

Physiol Genomics. 2015 Jun;47(6):187-97. doi: 10.1152/physiolgenomics.00136.2014. Epub 2015 Mar 31.

21.

The compensatory enrichment of sphingosine -1- phosphate harbored on glycated high-density lipoprotein restores endothelial protective function in type 2 diabetes mellitus.

Tong X, Lv P, Mathew AV, Liu D, Niu C, Wang Y, Ji L, Li J, Fu Z, Pan B, Pennathur S, Zheng L, Huang Y.

Cardiovasc Diabetol. 2014 Apr 21;13:82. doi: 10.1186/1475-2840-13-82.

22.

Uremic solutes and risk of end-stage renal disease in type 2 diabetes: metabolomic study.

Niewczas MA, Sirich TL, Mathew AV, Skupien J, Mohney RP, Warram JH, Smiles A, Huang X, Walker W, Byun J, Karoly ED, Kensicki EM, Berry GT, Bonventre JV, Pennathur S, Meyer TW, Krolewski AS.

Kidney Int. 2014 May;85(5):1214-24. doi: 10.1038/ki.2013.497. Epub 2014 Jan 15.

23.

Paediatric post-septal and pre-septal cellulitis: 10 years' experience at a tertiary-level children's hospital.

Mathew AV, Craig E, Al-Mahmoud R, Batty R, Raghavan A, Mordekar SR, Chan J, Connolly DJ.

Br J Radiol. 2014 Jan;87(1033):20130503. doi: 10.1259/bjr.20130503. Epub 2013 Nov 28.

24.

Autophagy deficiency by hepatic FIP200 deletion uncouples steatosis from liver injury in NAFLD.

Ma D, Molusky MM, Song J, Hu CR, Fang F, Rui C, Mathew AV, Pennathur S, Liu F, Cheng JX, Guan JL, Lin JD.

Mol Endocrinol. 2013 Oct;27(10):1643-54. doi: 10.1210/me.2013-1153. Epub 2013 Aug 19.

25.

Metabolomics reveals signature of mitochondrial dysfunction in diabetic kidney disease.

Sharma K, Karl B, Mathew AV, Gangoiti JA, Wassel CL, Saito R, Pu M, Sharma S, You YH, Wang L, Diamond-Stanic M, Lindenmeyer MT, Forsblom C, Wu W, Ix JH, Ideker T, Kopp JB, Nigam SK, Cohen CD, Groop PH, Barshop BA, Natarajan L, Nyhan WL, Naviaux RK.

J Am Soc Nephrol. 2013 Nov;24(11):1901-12. doi: 10.1681/ASN.2013020126. Epub 2013 Oct 10.

26.

Metabolic signature of CKD: the search continues.

Mathew AV, Pennathur S.

Am J Kidney Dis. 2012 Aug;60(2):173-5. doi: 10.1053/j.ajkd.2012.05.005. No abstract available.

27.

AMPK mediates the initiation of kidney disease induced by a high-fat diet.

Declèves AE, Mathew AV, Cunard R, Sharma K.

J Am Soc Nephrol. 2011 Oct;22(10):1846-55. doi: 10.1681/ASN.2011010026. Epub 2011 Sep 15.

28.

Pirfenidone for diabetic nephropathy.

Sharma K, Ix JH, Mathew AV, Cho M, Pflueger A, Dunn SR, Francos B, Sharma S, Falkner B, McGowan TA, Donohue M, Ramachandrarao S, Xu R, Fervenza FC, Kopp JB.

J Am Soc Nephrol. 2011 Jun;22(6):1144-51. doi: 10.1681/ASN.2010101049. Epub 2011 Apr 21.

29.

Obesity related kidney disease.

Mathew AV, Okada S, Sharma K.

Curr Diabetes Rev. 2011 Jan;7(1):41-9. Review.

PMID:
21067508
30.

Electrolyte imbalances in pediatric living related small bowel transplantation.

Beier UH, Kaplan B, Setty S, Samuel S, Mathew AV, Oberholzer J, Benedetti E, John E.

Transplantation. 2008 Jan 27;85(2):217-23. doi: 10.1097/TP.0b013e31816025b4.

PMID:
18212626
31.

Early coronary calcification in children and young adults with end-stage renal disease.

Lumpaopong A, Mathew AV, John E, Jelnin V, Benedetti E, Testa G, Oberholzer J, Sankary H, Ruiz C.

Transplant Proc. 2007 Jan-Feb;39(1):37-9.

PMID:
17275470

Supplemental Content

Loading ...
Support Center